You are here

China's godmother of biotechnology eyes blockbuster second act

Hong Kong

IT'S been more than a decade since Samantha Du returned to China to build one of its first biotechnology companies focused on developing drugs for a global market. Back then, she trained scientists, had perplexing discussions with regulators new to the field and worked hard to...

Market voices on: